Avantax Planning Partners’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-32,174
| Closed | -$274K | – | 483 |
|
|
2024
Q2 | $274K | Hold |
32,174
| – | – | 0.01% | 374 |
|
|
2024
Q1 | $329K | Hold |
32,174
| – | – | 0.01% | 349 |
|
|
2023
Q4 | $176K | Hold |
32,174
| – | – | 0.01% | 365 |
|
|
2023
Q3 | $122K | Hold |
32,174
| – | – | 0.01% | 351 |
|
|
2023
Q2 | $216K | Hold |
32,174
| – | – | 0.01% | 347 |
|
|
2023
Q1 | $209K | Hold |
32,174
| – | – | 0.01% | 351 |
|
|
2022
Q4 | $274K | Hold |
32,174
| – | – | 0.01% | 309 |
|
|
2022
Q3 | $170K | Hold |
32,174
| – | – | 0.01% | 330 |
|
|
2022
Q2 | $136K | Hold |
32,174
| – | – | 0.01% | 328 |
|
|
2022
Q1 | $113K | Buy |
+32,174
| New | +$113K | ﹤0.01% | 347 |
|